These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 157805)
1. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil. Washtien WL; Santi DV Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805 [TBL] [Abstract][Full Text] [Related]
2. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels. Grem JL; Fischer PH Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS. Carli D; Honorat M; Cohen S; Megherbi M; Vignal B; Dumontet C; Payen L; Guitton J J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2937-44. PubMed ID: 19620028 [TBL] [Abstract][Full Text] [Related]
4. Competitive binding radioassay for 5-fluorodeoxyuridine 5'-monophosphate in tissues. Murinson DS; Anderson T; Schwartz HS; Myers CE; Chabner BA Cancer Res; 1979 Jul; 39(7 Pt 1):2471-5. PubMed ID: 445447 [TBL] [Abstract][Full Text] [Related]
5. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil. Washtien WL Mol Pharmacol; 1984 Jan; 25(1):171-7. PubMed ID: 6708932 [TBL] [Abstract][Full Text] [Related]
7. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Houghton JA; Maroda SJ; Phillips JO; Houghton PJ Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754 [TBL] [Abstract][Full Text] [Related]
8. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189 [TBL] [Abstract][Full Text] [Related]
9. Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2'-deoxyuridine-5'-monophosphate by high-performance liquid chromatography. Dreyer R; Cadman E J Chromatogr; 1981 Dec; 219(2):273-84. PubMed ID: 6274888 [TBL] [Abstract][Full Text] [Related]
10. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. Boothman DA; Briggle TV; Greer S Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263 [TBL] [Abstract][Full Text] [Related]
11. Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue. Miyata S; Mikami H; Tai M; Hori T; Fujita H Jpn J Cancer Res; 1991 Jun; 82(6):742-6. PubMed ID: 1830300 [TBL] [Abstract][Full Text] [Related]
12. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. Chadwick M; Chang C Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772 [TBL] [Abstract][Full Text] [Related]
13. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate. Fernandes DJ; Moroson BA; Bertino JR Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations. Tanaka M; Kimura K; Yoshida S Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512 [TBL] [Abstract][Full Text] [Related]
15. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. Moran RG; Spears CP; Heidelberger C Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1456-60. PubMed ID: 108681 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844 [TBL] [Abstract][Full Text] [Related]
17. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index. Armstrong RD; Diasio RB Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343 [TBL] [Abstract][Full Text] [Related]
18. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil. Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433 [TBL] [Abstract][Full Text] [Related]
19. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies. Jackman AL; Alison DL; Calvert AH; Harrap KR Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731 [TBL] [Abstract][Full Text] [Related]
20. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. Myers CE; Young RC; Chabner BA J Clin Invest; 1975 Nov; 56(5):1231-8. PubMed ID: 1184747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]